Ghost Tree Capital LLC reduced its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 31.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 550,000 shares of the technology company’s stock after selling 250,000 shares during the quarter. Cogent […]